#Switzerland #Biopharma #Basel #Zifo #Basel Event

A New Era in Biopharma Data Management at Zifo's SiEE Basel

The 2026 Scientific Informatics Experience Exchange (SiEE), held in Basel, Switzerland, brought together leading experts from major pharmaceutical companies such as Roche, Bayer, and Novo Nordisk. The event's primary focus was on ensuring that the biopharma industry lays a solid foundation of data before diving headfirst into the fast-paced world of AI technologies. This gathering aimed to tackle what is considered the most significant challenge facing the industry: how to effectively use existing data to prepare for future innovations.

Importance of Data Over AI Hype

In an age where AI dominates conversations across sectors, the experts at SiEE emphasized the necessity of proper data governance as the backbone for any advanced technology implementation. Attendees were presented with technical frameworks to tackle structural challenges and were encouraged to prioritize the integration of quality data that supports AI initiatives rather than succumbing to the prevailing hype surrounding these technologies.

Marc de Luca, Global Product Owner for LIMS at Bayer, spearheaded discussions about the importance of establishing strict governance to ensure the data landscape aligns with the regulatory and operational demands of the biopharma sector. Strategies to automate workflows effectively, especially at the cyber-physical interface, were key topics explored throughout the summit.

Engaging Panel Discussions

A highlight of the event was a panel discussion incorporating thought leaders such as Ercan Sükür from Roche and Andrea Capuccio of Galapagos. They discussed megatrends in the scientific industry, scrutinizing how each organization could adapt and prepare itself for the future of scientific informatics. The conversation pivoted around a common theme: the need for biopharma companies to scale their digital workflow capabilities without compromising on data integrity and quality.

From automation to adoption, the discussions underscored the relevance of implementing workflows that are not only efficient but are equally responsive to evolving industry standards. Arndt Finklemann from Syngenta facilitated conversations focusing on collaborative approaches to achieve greater alignment in digital transformation efforts.

Looking Ahead: The Roadmap Toward Digital Biopharma

Paul Denny-Gouldson, Zifo’s Chief Scientific Officer, concluded the summit with a powerful message urging participants to treat scientific data as their most critical strategic asset. He pointed out that fostering a culture of scientific understanding and cross-functional collaboration is imperative for scaling advanced digital initiatives. According to Denny-Gouldson, robust data governance is the first step toward achieving not only today’s AI endeavors but preparing for the inevitable revolutions in processing technology of the future.

Zifo’s Position in the Industry

Zifo stands out as a leading provider of data-driven enterprise informatics for science-driven organizations. Their work spans across various fields, including pharmaceuticals, biotechnology, and chemicals. With cutting-edge solutions tailored to research, development, and clinical domains, Zifo partners with over 190 organizations worldwide, thus significantly contributing to scientific innovation and the advancement of digital biopharma initiatives.

For more insights from the SiEE Basel event, visit Zifo's official page. This summit epitomizes a transformative approach in the biopharma landscape, urging professionals to prioritize data quality and governance as the essential blueprint for technological growth in the coming years.